5 unchanged sentences
Rights Agreement, by and between the Registrant and certain of its stockholders, dated April 15, 2021, as amended (incorporated by reference to Exhibit 4.2 to the Registrant’s Registration Statement on Form S-1, filed June 7, 2021).
−Removed: Janux Therapeutics, Inc.
−Removed: 2021 Equity Incentive Plan, and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder (incorporated by reference to Exhibit 10.3 to the Registrant’s Registration Statement on Form S-1, as amended, filed June 7, 2021).
−Removed: Janux Therapeutics, Inc.
−Removed: 2021 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.4 to the Registrant’s Registration Statement on Form S-1, as amended, filed June 7, 2021).
−Removed: Non-Employee Director Compensation Policy (incorporated by reference to Exhibit 10.5 to the Registrant’s Registration Statement on Form S-1, as amended, filed June 7, 2021).
−Removed: Cell Line License Agreement by and between the registrant and WuXi Biologics (Hong Kong) Limited, dated April 19, 2021 (incorporated by reference to Exhibit 10.10 to the Registrant’s Registration Statement on Form S-1, filed June 7, 2021).
−Removed: Employment Agreement, by and between the registrant and Wayne Godfrey, M.D., dated May 4, 2021 (incorporated by reference to Exhibit 10.13 to the Registrant’s Registration Statement on Form S-1, filed June 7, 2021).
+Added: Lease, by and between the Registrant and UTC Properties LLC, dated August 25, 2021.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
10 unchanged sentences
Cover Page Interactive Data File (embedded within the Inline XBRL document)
−Removed: * Filed herewith.
−Removed: + Indicates management contract or compensatory plan.
−Removed: Certain portions of this exhibit are omitted because they are not material and would likely cause competitive harm to the registrant if disclosed.
+Added: # The information in Exhibit 32.1 shall not be deemed “filed”
+Added: for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act (including this Quarterly Report on Form 10-Q), unless the Registrant specifically incorporates the foregoing information into those documents by reference.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
JANUX THERAPEUTICS, INC.
−Removed: August 10, 2021
+Added: November 9, 2021
/s/ David Campbell
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 10, 2021
+Added: November 9, 2021
/s/ Tighe Reardon
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.